Invention Grant
- Patent Title: PEG-urate oxidase conjugates and use thereof
-
Application No.: US14806494Application Date: 2015-07-22
-
Publication No.: US09885024B2Publication Date: 2018-02-06
- Inventor: L. David Williams , Michael S. Hershfield , Susan J. Kelly , Mark G. P. Saifer , Merry R. Sherman
- Applicant: Duke University , Crealta Pharmaceuticals LLC
- Applicant Address: US NC Durham US IL Lake Forest
- Assignee: DUKE UNIVERSITY,HORIZON PHARMA RHEUMATOLOGY LLC
- Current Assignee: DUKE UNIVERSITY,HORIZON PHARMA RHEUMATOLOGY LLC
- Current Assignee Address: US NC Durham US IL Lake Forest
- Agency: Lando & Anastasi, LLP
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C12N9/06 ; C12N9/02 ; C12N9/96 ; A61K47/60

Abstract:
A naturally occurring or recombinant urate oxidase (uricase) covalently coupled to poly(ethylene glycol) or poly(ethylene oxide) (both referred to as PEG), wherein an average of 2 to 10 strands of PEG are conjugated to each uricase subunit and the PEG has an average molecular weight between about 5 kDa and 100 kDa. The resulting PEG-uricase conjugates are substantially non-immunogenic and retain at least 75% of the uricolytic activity of the unmodified enzyme.
Public/Granted literature
- US20160160188A1 PEG-Urate Oxidase Conjugates and Use Thereof Public/Granted day:2016-06-09
Information query
IPC分类: